Compared to the aggregate P/E ratio of the 192.07 in the Biotechnology industry, United Therapeutics Inc. has a lower P/E ...
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback